2,157
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig

, , , , , , , , , & show all
Pages 273-280 | Received 24 Dec 2018, Accepted 04 Feb 2019, Published online: 16 Mar 2019

References

  • Ansari MJ, Anwer MK, Jamil S, et al. (2016). Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Deliv 23:1972–9.
  • Elmas M, Uney K, Yazar E, et al. (2007). Pharmacokinetics of enrofloxacin following intravenousand intramuscular administration in Angora rabbits. Res Vet Sci 82:242–5.
  • Elsheikh HA, Taha AAW, Khalafallah AI, Osman IAM. (2002). Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goatsfollowing intravenous and intramuscular injection using a microbiologicalassay. Res Vet Sci 73:125–9.
  • Harada K, Usui M, Asai T. (2014). Application of enrofloxacin and orbifloxacin disks approved in japan for susceptibility testing of representative veterinary respiratory pathogens. J Vet Med Sci 76:1427–30.
  • Haritova A, Lashev L, Pashov D. (2003). Pharmacokinetics of enrofloxacin in lactating sheep. Res Vet Sci 74:241–5.
  • Ji H, Tang J, Li M, et al. (2016). Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv 23:459–70.
  • Li XQ, Xie SY, Pan YH, et al. (2016). Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl–cyclodextrin inclusion complexes. Coll Surf B: biointerfaces 6:634–42.
  • Luo Y, Chen D, Ren L, et al. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Rel 114:53–9.
  • Martinez M, McDermott P, Walker R. (2006). Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J 172:10–28.
  • Mehnert W, Mader K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliver Rev 47:165–96.
  • Ruennarong N, Wongpanit K, Sakulthaew C, et al. (2016). Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes. J Veter Med Sci 78:397–403.
  • Soliman GM. (2017). Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int J Pharm 527:15–32.
  • Tiwari RV, Polk AN, Patil H, et al. (2017). Rat palatability study for taste assessment of caffeine citrate formulation prepared via hot-melt extrusion technology. AAPS PharmSciTech 18:341–8.
  • Wang Y, Zhu LY, Dong Z, et al. (2012). Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions. Coll Surf B: biointerfaces 98:105–11.
  • Xie SY, Pan B, Wang M, et al. (2010). Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil-solid lipid nanoparticles. Nanomedicine 5:693–701.
  • Xie SY, Wang SL, Zhao BK, et al. (2008). Effect ofPLGA as a polymeric emulsifer on preparation of hydrophilic protein loaded solid lipid nanoparticles. Coll Surf. B: biointerfaces 67:199–204.
  • Xie SY, Yang F, Tao YF, et al. (2017). Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella. Sci Rep 7:41104.
  • Xie SY, Zhu LY, Dong Z, et al. (2011). Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. Coll Surf. B: biointerfaces 83:382–7.
  • Yang F, Kang JJ, Yang F, et al. (2015). Preparation and evaluation of enrofloxacin microspheres and tissue distribution in rats. J Vet Sci 16:157–64.